Ostarine, often known as MK-2866 or enobosarm, belongs to your category of selective androgen receptor modulators. It was originally developed by Merck & Enterprise and is also below investigation for its potential to deal with serious disorders for instance muscle losing and osteoporosis. The compound’s selective receptor exercise and favorab